Author:
Sutherland Lloyd R,MacDonald John K
Reference91 articles.
1. 5-aminosalicylic acid versus salazopirin (SASP) in the oral treatment of active ulcerative colitis (UC) and in remission [abstract];Andreoli;Clinical Controversies in Inflammatory Bowel Disease,1987
2. Olsalazine versus placebo in the treatment of mild to moderate ulcerative colitis: a randomised double-blind trial;Feurle;Gut,1989
3. Prospective, randomized, double-blind comparison of benzalazine and sulfasalazine in the treatment of active ulcerative colitis;Fleig;Digestion,1988
4. A double-blind comparison of controlled release mesalamine tablets and sulfasalazine in the treatment of ulcerative colitis [abstract];Good;Gastroenterology,1992
5. A double-blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3g daily, in patients with newly diagnosed or relapsed active ulcerative colitis;Green;Aliment Pharmacol Ther,2002
Cited by
129 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献